FDMDF 0.22 4DMedical Limited
| Range: | 0.3204-0.6008 | Vol Avg: | 21 | Last Div: | 0 | Changes: | -0.05 |
| Beta: | 1.26 | Cap: | 0.13B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Tue Feb 02 2021 | Empoloyees: | 145 | ||
| CUSIP: | CIK: | ISIN: | AU0000095416 | Country: | AU | ||
| CEO: | Dr. Andreas Fouras M.A.I.C.D., Ph.D. | Website: | https://www.4dmedical.com | ||||
4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lung ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator. The company was incorporated in 2012 and is based in Carlton, Australia.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow